Daniel M. Schmitt - President, CEO and Director, Director at Actuate Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, CEO and Director, Director
Stock Symbol
ACTU on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Daniel M. Schmitt since 11/26/2024

Holdings reported by Daniel M. Schmitt for Actuate Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 564K $2.97M $5.27 Aug 12, 2024 By The Schmitt Family Irrevocable Trust, dated December 31, 2019
Common Stock 22.2K $117K $5.27 Aug 12, 2024 By The Andrew Schmitt Irrevocable Trust, dated December 31, 2019
Common Stock 22.2K $117K $5.27 Aug 12, 2024 By The Anna Schmitt Irrevocable Trust, dated December 31, 2019
Common Stock 22.2K $117K $5.27 Aug 12, 2024 By The Edward Schmitt Irrevocable Trust, dated December 31, 2019
Employee Stock Option (right to buy) 204K Apr 1, 2025 Direct Common Stock
Restricted Stock Units 0 Aug 14, 2024 Direct Common Stock

Transactions reported by Daniel M. Schmitt for Actuate Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.